In a pan-cancer study evaluating the -intra and -inter tumor heterogeneity of the KMT2 gene, it was noted that KMT2B expression was significantly upregulated in 18 tumor types, including BC subtypes, which correlated with an aggressive phenotype [32]. This evidence concerns the gene KMT2B and breast cancer.